Innate Pharma (IPH) — Cash Flow-to-Debt Ratio
Innate Pharma (IPH) has a Cash Flow-to-Debt Ratio of -0.26x as of December 2025, meaning its operating cash flow of €-21.59 Million could theoretically repay 0% of its total liabilities (€84.42 Million) in one year. Explore investment intensity of Innate Pharma to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Innate Pharma Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Innate Pharma across 21 annual periods. Also explore balance sheet size of Innate Pharma for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Innate Pharma (2005–2025)
Year-by-year debt coverage analysis for Innate Pharma. For market capitalisation and broader financial context, see IPH market cap.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.62x | €-52.76 Million | €84.42 Million | ▼ -826.3% |
| 2024 | -0.07x | €-6.90 Million | €102.22 Million | ▲ +72.6% |
| 2023 | -0.25x | €-32.56 Million | €132.29 Million | ▼ -97.5% |
| 2022 | -0.12x | €-19.15 Million | €153.71 Million | ▲ +65.9% |
| 2021 | -0.37x | €-58.46 Million | €160.06 Million | ▼ -6.8% |
| 2020 | -0.34x | €-51.81 Million | €151.45 Million | ▼ -280.2% |
| 2019 | 0.19x | €34.92 Million | €183.94 Million | ▲ +265.7% |
| 2018 | -0.11x | €-32.53 Million | €283.98 Million | ▲ +59.7% |
| 2017 | -0.28x | €-48.06 Million | €169.07 Million | ▼ -50.7% |
| 2016 | -0.19x | €-36.85 Million | €195.41 Million | ▼ -121.2% |
| 2015 | 0.89x | €207.91 Million | €233.89 Million | ▲ +178.7% |
| 2014 | -1.13x | €-18.13 Million | €16.06 Million | ▼ -60.5% |
| 2013 | -0.70x | €-10.97 Million | €15.60 Million | ▼ -67.4% |
| 2012 | -0.42x | €-10.47 Million | €24.93 Million | ▼ -208.3% |
| 2011 | 0.39x | €12.99 Million | €33.48 Million | ▲ +141.8% |
| 2010 | -0.93x | €-13.45 Million | €14.49 Million | ▼ -167.3% |
| 2009 | -0.35x | €-5.94 Million | €17.10 Million | ▲ +54.0% |
| 2008 | -0.76x | €-14.74 Million | €19.52 Million | ▼ -10.2% |
| 2007 | -0.69x | €-9.28 Million | €13.55 Million | ▼ -2552.5% |
| 2006 | 0.03x | €360.00K | €12.89 Million | ▲ +101.8% |
| 2005 | -1.54x | €-7.25 Million | €4.70 Million | — |